E NUMBER
Dead / Abandoned — Abandoned — failure to respond (as of 10 Jun 2023)
What this means for you
This application is over — abandoned 15 May 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97324640
- Mark type
- Stylized text
- Filed
- 22 Mar 2022
- Abandoned
- 15 May 2023
- Attorney of record
- Julian Gonzalez
Goods and services
- Class 001 — Chemicals: Assays for research purposes; Non-medical biological and chemical reagents used for detecting and analyzing molecules in proteins or nucleotides, in vitro and in vivo scientific use, and testing of bodily fluids; Chemical test kits for personal wellness for research use; Chemical test kits for the detection and identification of nucleic acids, namely, DNA and RNA in a sample for research or laboratory use
- Class 005 — Pharmaceuticals: Drug testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids; Medical diagnostic reagents and assays for testing bodily fluids for microorganisms; Medical diagnostic reagents and assays for testing of bodily fluids; Tests for personal wellness, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical testing kits comprising reagents and assays for the detection and identification of nucleic acids, namely, DNA and RNA in a sample
- Class 010 — Medical apparatus: Medical diagnostic apparatus for testing cells, tissue and biomolecules, in the nature of proteins, small molecules, cells, and nucleic acids; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Devices for personal wellness, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic instruments, namely, instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample
- Class 042 — Scientific and technological services: Detection and identification of nucleic acids, namely, DNA and RNA in a sample for scientific, research, and technological purposes
- Class 044 — Medical, beauty and agricultural services: Medical assistance; Medical consultations; Medical counseling; Medical information; Medical services; Tests for personal wellness, namely, testing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of nucleic acids, namely, DNA and RNA in a sample
Owner
- Essenlix Corporation, Monmouth Junction, NJ, US
Prosecution history
- 12 Jun 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 10 Jun 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 10 Jun 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 11 Feb 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Feb 2023 — NON-FINAL ACTION E-MAILED
- 11 Feb 2023 — NON-FINAL ACTION WRITTEN
- 17 Dec 2022 — ASSIGNED TO EXAMINER
- 28 Mar 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Mar 2022 — NEW APPLICATION ENTERED